SCHEMBL883334

SCHEMBL883334

CCCn1c2c(c3ccccc31)C(C(=O)N(C)Cc1ccccc1)CCC2

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15101782 0.93 TSPO (0.70) TSPO
SCHEMBL414227 0.93 TSPO (0.61) TSPO
SCHEMBL415392 0.93 TSPO (0.70) TSPO
SCHEMBL416794 0.88 TSPO (0.56) TSPO
SCHEMBL416453 0.87 TSPO (0.55) TSPO
SCHEMBL19590564 0.84 TSPO (0.64) TSPO
SCHEMBL30106153 0.83 TSPO (0.84) TSPO
SCHEMBL17940511 0.83 TSPO (0.84) TSPO
SCHEMBL17940512 0.83 TSPO (0.84) TSPO
SCHEMBL11822650 0.80 HTR6 (0.67) TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038532-A1 IN VIVO IMAGING METHOD OF MOOD DISORDERS GE HEALTHCARE LIMITED (GB) 2012-03-29 WO disclosed